Adrienne Elizabeth Milward

Prof. Adrienne Elizabeth Milward

orcid

Research Focus & Metrics

Academic Career Length

17Years (2010-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
18 June 2012 in Journal of Alzheimer’s Disease
Verified
Journal Article
Closed access
DJDaniel Johnstone
Daniel Johnstone
RGRoss M Graham
Ross M Graham
DTDebbie Trinder
Debbie Trinder
CRCarlos Riveros
Carlos Riveros
JOJohn Olynyk
John Olynyk
AMAdrienne Elizabeth Milward
Adrienne Elizabeth Milward
Iron abnormalities are observed in the brains of Alzheimer's disease (AD) patients, but it is unclear whether common disorders of systemic iron overload such as hemochromatosis alter risks of AD. We used microarrays and real-time reverse transcription-PCR to investigate changes in the brain transcriptome of adult Hfe-/- mice, a model of hemochromatosis, relative to age- and gender-matched wildtype controls. Classification by functional pathway analysis revealed transcript changes for various genes important in AD. There were decreases of up to 9-fold in transcripts for amyloid-β protein precursor, tau, apolipoprotein E, presenilin 1, and various other γ-secretase components, as well as Notch signaling pathway molecules. This included decreased transcripts for 'hairy and enhancer of split' Hes1 and Hes5, downstream targets of Notch canonical signaling. The reductions in Hes1 and Hes5 transcripts provide evidence that the changes in levels of transcripts for γ-secretase components and Notch signaling genes have functional consequences. The effects appeared relatively specific for AD in that few genes pertaining to other important neurodegenerative diseases, notably Parkinson's disease and Huntington's disease, or to inflammation, oxidative stress, or apoptosis, showed altered transcript levels. The observed effects on AD-related gene transcripts do not appear to be consistent with increased AD risk in HFE hemochromatosis and might, if anything, be predicted to protect against AD to some extent. As Hfe-/- mice did not have higher brain iron levels than wildtype controls, these studies highlight the need for further research in models of more severe hemochromatosis with brain iron loading.

15 February 2010 in Journal of Endocrinological Investigation
Verified
Journal Article
Closed access
PDF file
BYBu B. Yeap
Bu B. Yeap
JBJ. Beilin
J. Beilin
Zumin ShiZumin Shi
Zumin Shi
MKM. W. Knuiman
M. W. Knuiman
JOJohn Olynyk
John Olynyk
AMAdrienne Elizabeth Milward
Adrienne Elizabeth Milward

1 December 2024 in Alzheimer's & Dementia
Verified
Journal Article
Open access
AMAdrienne Elizabeth Milward
Adrienne Elizabeth Milward
RARitambhara Aryal
Ritambhara Aryal
EAElvis Acquah
Elvis Acquah
DJDaniel Johnstone
Daniel Johnstone
Background: UK Biobank data show mutations related to the iron disorder hemochromatosis can approximately double the risk of dementia, in particular clinically diagnosed vascular dementia. Insights into the etiology of this dementia may be provided by cerebrovasculopathy in our new “Aβ+Irondys” mouse model, which combines hemochromatosis‐related mutations and amyloidosis, with increases in soluble Aβ species and plaques. This was created by crossing an established APP/PS1 model of β‐amyloidosis with our reported Hfe‐/‐xTfr2mut model of hemochromatosis‐related mutations exhibiting brain iron dyshomeostasis (Heidari Mol. Psych. 2016).Method: Deposition of amyloid and other Aβ species was visualized by Congo red, thioflavins and Aβ immunolabeling. Iron was visualized by diaminobenzidine (DAB)‐enhanced Perls’ or transcardially perfused DAB+Turnbull’s staining.Result: Compared to regular APP/PS1 mice, Aβ+Irondys mice have extensive cerebrovasculopathy, sometimes severe, at 6 months and older. This is typically accompanied by iron deposition in vessel walls, sometimes co‐localizing with amyloid (Congo Red birefringence). Cerebrovasculopathy includes enlarged perivascular spaces, tortuosity, wall thickening, lumenal stenosis, microaneurysm, anastomosis and other changes in vessel profiles and diameter, wall rupture and microhemorrhage. Intense parenchymal staining for iron adjoining cortical vessels may arise from ruptured vessels.Conclusion: Co‐deposition of iron and Aβ within blood vessels is exacerbated by hemochromatosis‐related mutations and can cause severe cerebrovasculopathy and amyloid angiopathy. This could lead to neuronal hypoperfusion and dysfunction throughout the brain in early disease stages and ultimately to neurodegeneraion. This has potential implications for understanding the etiology of dementia related to hemochromatosis mutations and for the clinical diagnosis of dementia subtypes.

7 May 2025 in bioRxiv
Verified
Preprint
Open access
PDF file
EFElvis Freeman-Acquah
Elvis Freeman-Acquah
RHRebecca J. Hood
Rebecca J. Hood
CLChan-An Lin
Chan-An Lin
QLQiao-Xin Li
Qiao-Xin Li
LGLuke Gordon
Luke Gordon
DJDaniel Johnstone
Daniel Johnstone
UK Biobank studies show Parkinson’s disease risk is almost doubled in men homozygous for the homeostatic iron regulator gene HFE p.C282Y polymorphism, associated with the common genetic iron disorder hemochromatosis. Whether this relationship is causal or spurious is unknown. We previously reported a novel Hfe -/- xTfr2 mut mouse model of hemochromatosis with elevated brain iron (∼1.5-1.8x). We now show these mice have reduced substantia nigra tyrosine hydroxylase expression at 3 months and 9 months age, sometimes exhibit severe hindlimb clasping by 7-8 months, have impaired rotarod and balance beam performance at 9 months and are untestable on the pole test. These parkinsonian features place the model at the forefront of genetic mouse models of PD, which generally do not show both TH loss and motor impairment. This confirms hemochromatosis-related mutations can cause parkinsonian features, substantiating causality of epidemiological relationships. Despite total brain iron elevation, neuronal iron remains low in Hfe -/- xTfr2 mut mice, consistent with hemochromatosis-related mutations disrupting the normal, iron-responsive regulation of the neuronal iron exporter ferroportin by hepcidin. Parkinsonian features may reflect reduced mitochondrial respiratory complex (MRC) activity due to functional neuronal iron depletion. This may be exacerbated by indiscriminate chelation and could instead respond to drugs targeting the hepcidin-ferroportin axis or MRC activity. This new model of chronic parkinsonism that increases with age provides unprecedented insights into the complex relationships of brain iron regulation and movement impairment. Since parkinsonism of diverse etiologies can exhibit iron dysregulation, the model may facilitate pre-clinical to end-stage studies relevant to both sporadic and genetic PD.

23 April 2025 in Preprints.org
Verified
Preprint
Open access
PDF file
AMAdrienne Elizabeth Milward
Adrienne Elizabeth Milward
RHRebecca J. Hood
Rebecca J. Hood
CLChan-An Lin
Chan-An Lin
CBConceição Bettencourt
Conceição Bettencourt
EAElvis Freeman Acquah
Elvis Freeman Acquah
DJDaniel Johnstone
Daniel Johnstone
The ontological categorization of the cellular elements of the brain was proposed over a century ago by Santiago Ramón y Cajal (neurons, astroglia) and Pío del Río-Hortega (oligodendroglia, microglia). It combines histochemical observations of morphology with allied inferences about the specialized functions and origins (ectoderm or mesoderm) of each cellular element. This ontology shapes modern neuroscience, with the main non-neuronal cells – astroglia, oligodendroglia and microglia – viewed as having distinct primary roles relating to metabolic support, myelination and protection of neurons, the information signaling cells. Yet contemporary techniques, ranging from electrophysiology to single-cell transcriptomics and ultrahigh resolution spectroscopy, are revealing intersecting molecular profiles and functional capacities of these cell groups, for example metabolic support, neuroimmune and signaling functions in oligodendroglia. Here we identify discrepancies in current glial paradigms from empirical, evolutionary and pragmatic perspectives. We suggest that a subset of cells often viewed as oligodendroglia instead have iron-related primary functions that are central to all aspects of brain activity, rather than myelin-related primary functions. We discuss implications for pathogenesis across the spectrum of neuropsychiatric and neurological disorders, including neurodegenerative conditions such as Alzheimer’s disease and other less common cognitive, movement and neurobehavioral disorders, stroke and cerebrovascular disease, glioblastoma and other brain cancers and neuroimmune conditions. We also briefly address the question of where these cells reside within existing glial compartments and lineages, implications for the ontological classification of other glial cells and research limitations that must be overcome going forward.

13 March 2026 in Cells
Verified
Journal Article
Open access
PDF file
AMAdrienne Elizabeth Milward
Adrienne Elizabeth Milward
RHRebecca J. Hood
Rebecca J. Hood
CLChan-An Lin
Chan-An Lin
CBConceição Bettencourt
Conceição Bettencourt
EAElvis Freeman Acquah
Elvis Freeman Acquah
DJDaniel Johnstone
Daniel Johnstone
The ontological categorization of the cellular elements of the brain was proposed over a century ago by Santiago Ramón y Cajal (neurons, astroglia) and Pío del Río-Hortega (oligodendroglia, microglia). It combines histochemical observations of morphology with allied inferences about the specialized functions and origins (ectoderm or mesoderm) of each cellular element. This ontology shapes modern neuroscience, with the main non-neuronal cells—astroglia, oligodendroglia and microglia—viewed as having distinct primary roles relating respectively to the metabolic support, myelination and immunoprotection of neurons, the information signaling cells. Yet contemporary techniques, ranging from electrophysiology to single-cell transcriptomics and ultrahigh resolution spectroscopy, are revealing intersecting molecular profiles and functional capacities of these cell groups, for example metabolic support, neuroimmune and signaling functions in oligodendroglia. Here we identify discrepancies in current glial paradigms, from empirical, evolutionary and pragmatic perspectives. We suggest a subset of small, iron-rich glial cells, usually with few processes, often viewed as oligodendroglia with myelin-related primary functions, instead have iron-related primary functions that are central to all aspects of brain activity. We call these ‘ferriglia’. We discuss implications for pathogenesis across the spectrum of neuropsychiatric and neurological disorders, including neurodegenerative conditions such as Alzheimer’s disease and other less common cognitive, movement and neurobehavioral disorders, stroke and cerebrovascular disease, glioblastoma and other brain cancers and neuroimmune conditions. We also briefly address the question of where ferriglia may reside within existing glial compartments and lineages, implications for the ontological classification of other glial cells, and research challenges that must be overcome going forward.